News Quantified

DNTH – dianthus therapeutics, inc. (US:NASDAQ)

Dianthus Therapeutics (NASDAQ:DNTH) had its price target raised by analysts at Wedbush from $46.00 to $55.00. They now have an "outperform" rating on the stock.

2/5

07:13 am

dnth

Low

Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]

Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Dianthus Therapeutics (NASDAQ:DNTH) had its price target raised by analysts at Jefferies Financial Group Inc. from $66.00 to $81.00. They now have a "buy" rating on the stock.

Assessing Dianthus Therapeutics (DNTH) Valuation As Price To Book Sits Near 3x And Shares Show Mixed Returns [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}